Variation in the OPRM1 gene (rs1799971) potentially reduces the response to buprenorphine [20,21], and the G allele associated with potentially reduced response has also been implicated as a risk allele for opioid use disorder in genome-wide association studies [28]. This evidence concerns the gene OPRM1 and opioid use disorder.